PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PHIP | Pleckstrin homology domain interacting protein | Predicted intracellular proteins
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | Predicted intracellular proteins
| | | | | Group enriched |
RPS6KB1 | Ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IGF2BP2 | Insulin-like growth factor 2 mRNA binding protein 2 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PSMD9 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ARRB1 | Arrestin, beta 1 | Predicted intracellular proteins
| | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | Predicted intracellular proteins
| | | | | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GLUL | Glutamate-ammonia ligase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HMGN3 | High mobility group nucleosomal binding domain 3 | Predicted intracellular proteins
| | | | | Expressed in all |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PARP1 | Poly (ADP-ribose) polymerase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PC | Pyruvate carboxylase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PRKAR2A | Protein kinase, cAMP-dependent, regulatory, type II, alpha | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RPS6 | Ribosomal protein S6 | Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |
S100A6 | S100 calcium binding protein A6 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SIRT1 | Sirtuin 1 | Predicted intracellular proteins
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SMAD2 | SMAD family member 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
SORT1 | Sortilin 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
STAT1 | Signal transducer and activator of transcription 1, 91kDa | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
TARDBP | TAR DNA binding protein | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TLN1 | Talin 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ZNF106 | Zinc finger protein 106 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRRC2A | Proline-rich coiled-coil 2A | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RPS15 | Ribosomal protein S15 | Cancer-related genes Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |